Author - Craig Foley

Vaccine news keeps markets positive: ASX poised to open higher

12 Nov 2020 - The ASX looks set to open higher this morning for the sixth day in a row as tech shares jumped up in the US. Global markets are still excited about the Covid-19 vaccines expected. Russia reports that early results from trials of their Covid vaccine suggest it could be 92% effective. Telstra (ASX:TLS) is set to restructure into three separate entities, InfraCo Fixed, InfraCo Towers and ServeCo.

Read more...

Woolworths (ASX:WOW) promises 100% renewable electricity by 2025: ASX closed 1.7% higher

11 Nov 2020 - It has been a positive day of trade for the ASX closing 1.7% higher – it’s fifth consecutive gain. Energy companies did well today with Whitehaven Coal (ASX:WHC) and Oil Search (ASX:OHS) both seeing gains. Shares in Ramelius Resources (ASX:RMS) didn’t fare so well. Woolworths (ASX:WOW) has committed to use 100% renewable electricity by 2025.

Read more...

Rally continues with all sectors in the black: ASX tracking 1.3% higher at noon

11 Nov 2020 - The ASX has continued its rally throughout the morning and is now tracking 1.3% higher at noon. Shares in Virgin Money UK (ASX:VUK) and accounting software company Xero (ASX:XRO) did well today. Shares in JB Hi-Fi (ASX:JBH) fell lower. All sectors are in the black. Synlait Milk (ASX:SM1) has successfully completed the bookbuild for its approximately NZ$180 million underwritten placement.

Read more...

President Trump contracts Covid-19: Aus shares close 1.4% lower

02 Oct 2020 - The Aussie dollar has toppled, and US futures are looking bleak after confirmation that President Donald Trump and First Lady Melania Trump have contracted Covid-19. The session ended 1.4% lower as investors digested what the inevitable instability and uncertainty would mean for the Aussie market. All of the sectors finished in the red.

Read more...

Mesoblast (ASX:MSB) hits approval hurdle: Aus shares 0.9% lower at noon

02 Oct 2020 - The Australian share market opened lower and continued to sink in early trade. Most of the sectors have lost ground this morning, with energy stocks weighing heaviest on the market. Shares in regenerative medicine darling Mesoblast (ASX:MSB) tumbled around 40% this morning after news that the US FDA approval for its lead drug candidate was not going to be the smooth sailing investors had hoped for.

Read more...

Imugene (ASX:IMU) secures core US patent

02 Oct 2020 - Immuno-oncology company, Imugene (ASX:IMU) has been granted a patent from the US United States Patent and Trademark Office which it says protects its cancer growth factor immunotherapy platform.

Read more...